Walleye Capital LLC Myriad Genetics Inc Call Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$13.91 - $21.32 $114,062 - $174,824	-8,200 Reduced 80.39%	2,000 $38,000
Q3 2023 Nov 14, 2023	BUY	$15.99 - $23.22 $163,098 - $236,844	10,200 New	10,200 $163,000
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $456,274 - $765,180	-21,800 Reduced 79.27%	5,700 $155,000
Q3 2019 Nov 14, 2019	BUY	$22.08 - $47.08 $607,200 - $1.29 Million	27,500 New	27,500 $787,000
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $253,904 - $392,000	-11,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $301,616 - $388,640	11,200 New	11,200 $372,000

250

90.6M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $999M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.